Limosilactobacillus reuteri DSM 17648

Limosilactobacillus reuteri DSM 17648 · Novozymes A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Limosilactobacillus reuteri DSM 17648, covering 2025-09-22 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Limosilactobacillus Reuteri DSM 17648 in Healthy Adults Reporting Upper Gastrointestinal Discomfort [NA]

See pricing